Cidara Therapeutics Provides Corporate Update and Reports globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Shares of Cidara Therapeutics, Inc. (CDTX) gained over 13% on Thursday morning after the company announced it reacquired global development and commercial rights to CD388.
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Industry-leading revenue, $6,069,247 in FY2021Total working capital of $9,680,431 to fund operationsExpanded network to six clinics and three clinical research sitesContracted for eight clinical trialsGranted